[Intracavernous injections of prostaglandin E1 in the treatment of erection disorders]. 1991

G Beretta, and A Zanollo, and W Portalupi
Unità di Andrologia, Ospedale di Magenta, Milano.

Vasoactive drugs have been widely used for the treatment of impotence in the last years. Recently Prostaglandin E1 has been employed with success as a therapy in erection problems. The Authors have treated with Prostaglandin E1 209 patients complaining erection failure. Positive results were obtained in 155 patients (74,16%). No complications or side effects occurred. 129 patients of the 155 in which the test resulted positive were proposed a self-injection program and 115 accepted. Until now no side effects or complications occurred.

UI MeSH Term Description Entries
D007172 Erectile Dysfunction The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction. Impotence,Male Impotence,Male Sexual Impotence,Dysfunction, Erectile,Impotence, Male,Impotence, Male Sexual,Sexual Impotence, Male
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010410 Penile Erection The state of the PENIS when the erectile tissue becomes filled or swollen (tumid) with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions. Tumescence, Penile,Nocturnal Penile Tumescence,Penile Tumescence,Erection, Penile,Penile Tumescence, Nocturnal,Tumescence, Nocturnal Penile
D010413 Penis The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra. Glans Penis,Penis, Glans
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G Beretta, and A Zanollo, and W Portalupi
February 1993, Nederlands tijdschrift voor geneeskunde,
G Beretta, and A Zanollo, and W Portalupi
January 1987, Journal d'urologie,
G Beretta, and A Zanollo, and W Portalupi
May 1990, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
G Beretta, and A Zanollo, and W Portalupi
January 1996, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
G Beretta, and A Zanollo, and W Portalupi
January 1994, The Clinical investigator,
G Beretta, and A Zanollo, and W Portalupi
June 2002, Nihon rinsho. Japanese journal of clinical medicine,
G Beretta, and A Zanollo, and W Portalupi
February 1989, The Journal of urology,
G Beretta, and A Zanollo, and W Portalupi
February 1999, International journal of impotence research,
G Beretta, and A Zanollo, and W Portalupi
September 1991, The Journal of urology,
Copied contents to your clipboard!